A biopharmaceutical company
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
Kennedy Healthcare Reform Bill
House Tri Committee Healthcare Reform Bill
Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill
H.R. 2502 Comparative Effectiveness Research Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 Medicare Issues
S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009
Kennedy Healthcare Reform Bill
House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill
Senate Finance Healthcare Reform Bill
H.R. 2502 Comparative Effectiveness Research Act of 2009
S. 1213 Patient-Centered Outcomes Research Act of 2009 LHHS appropriations
Diabetes research issues
Comparative effectiveness
H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act
H.R. 1548 Pathway for Biosimilars Act
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act
Drug Importation/Drug Safety H.R. 1 American Recovery and Reinvestment Act of 2009
S. Con. Res. 13
H. Con. Res. 85 H.R. 1260 Patent Reform Act of 2009
S. 515 Patent Reform Act of 2009
S. 610 Patent Reform Act of 2009
HCR - Health Issues MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs PHA - Pharmacy BUD - Budget/Appropriations CPT - Copyright/Patent/Trademark
136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
PODESTA GROUP, INC.
1001 G Street, NW, Suite 1000 West, Washington, DC, 20001, US
SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) PAUL BRATHWAITE (DOT, General Counsel's Honors Program) SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) PAUL BRATHWAITE (DOT, General Counsel's Honors Program) SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) PAUL BRATHWAITE (DOT, General Counsel's Honors Program) SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) PAUL BRATHWAITE (DOT, General Counsel's Honors Program) SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) SHARON COHEN THOMAS B SPARKMAN (Health Policy Intern, Senate HELP Committee) COURTNEY HAGEN DANIELE BAIERLEIN PAUL BRATHWAITE (DOT, General Counsel's Honors Program)
Health Policy Intern, Senate HELP Committee DOT, General Counsel's Honors Program Health Policy Intern, Senate HELP Committee DOT, General Counsel's Honors Program Health Policy Intern, Senate HELP Committee DOT, General Counsel's Honors Program Health Policy Intern, Senate HELP Committee DOT, General Counsel's Honors Program Health Policy Intern, Senate HELP Committee Health Policy Intern, Senate HELP Committee DOT, General Counsel's Honors Program